ISPOR Exhibit Hall Theater - Live
The future of RWE: Claims and EMR were just the beginning
May 19, 3:30 – 4:00 p.m. EST
Theater 2, Poster & Exhibit Hall
Presentation objectives:
- Understand how fragmentation across the complex patient journey creates barriers to real-world evidence (RWE) generation
- Identify key challenges in integrating disparate data sources, including unstructured data
- Evaluate the role of data linkage and manual curation in resolving missing, redundant and misaligned data elements
- Review best practices for generating regulatory-grade RWE that accurately reflects real-world patient care
Moderator
 |
Amy Eaves VP, Real-World Data and Evidence |
Speakers
 |
Bruce Feinberg, DO Chief Medical Officer |
 |
Harlen Hays, MPH Senior Director, Scientific Operations and Analytics |
 |
Andy Klink, PhD, MPH Senior Director, Business Development, Real-World Data and Evidence |
ISPOR panel session
Aligning HEOR with global policy shifts: How should we lead and influence?
May 19, 12:15 – 1:15pm EST
This session featuring Dr. Bruce Feinberg from Cardinal Health and a panel of experts will discuss the evolving global policy landscape shaping drug pricing and access. The session will highlight the role of HEOR in informing pricing reforms and HTA frameworks, the importance of cross stakeholder collaboration, and practical ways to translate policy into effective access strategies.
Moderator:
Sulabha Ramachandran, PhD
GlaxoSmithKline, West Chester, PA, United States
Speakers:
- Arturo Cabra, BS, MSc
GE HealthCare, Miami, FL, United States - Bruce Feinberg, DO
Cardinal Health, Dublin, OH, United States - Marie Andrawes, PhD
Thermo Fisher Scientific, Newton, MA, United States - Claire Telford, MSc, PhD
Pfizer, Gaithersburg, MD, United States
